⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Akkermansia muciniphila and Bioactive Derivatives
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-01 — Associations Between Gut Microbiota and Immune Profiles in Community-Dwelling Older Adults and the Regulatory Role of Polygonatum odoratum.: cross-connection with polygonatum-odoratum: YZG supplementation increased gut Akkermansia abundance in older adults, linking a TCM herb intervention to the Akkermansia-immunity axis tracked separately in this area. (novelty: 3)
- 2026-08-10 — HB05P on Muscle Health: 24-week pilot RCT registered testing pasteurized A. muciniphila HB05 (HB05P, 3×10^10 cells/day) plus walking/resistance exercise vs exercise alone on isokinetic leg strength in adults 50–80 with sarcopenia or possible sarcopenia; protocol only, no readout yet. [human-rct] (novelty: 3)
- 2026-09-04 — Akkermansia muciniphila and Its Bioactive Derivatives: Emerging Regulators of Healthy Aging: 2026 Aging Cell narrative review consolidates A. muciniphila and its bioactive derivatives (Amuc_1100, extracellular vesicles, P9 protein) as candidate healthy-aging regulators acting via gut barrier integrity, metabolic, and immune pathways; no new human outcome trial reported. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Akkermansia muciniphila and Its Bioactive Derivatives: Emerging Regulators of Healthy Aging
04-sep-2026
novelty 3
per-area 3
strengthens
HB05P on Muscle Health
10-aug-2026
novelty 3
per-area 3
strengthens